The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.

Muñoz, Miguel; González-Ortega, Ana; Salinas-Martín, Manuel Vicente; Carranza, Andrés; Garcia-Recio, Susana; Almendro, Vanessa; Coveñas, Rafael

Muñoz, Miguel; González-Ortega, Ana; Salinas-Martín, Manuel Vicente; Carranza, Andrés; Garcia-Recio, Susana; Almendro, Vanessa; Coveñas, Rafael.

Affiliation

Muñoz M; Virgen del Rocío University Hospital, Research Laboratory on Neuropeptides, Sevilla, Spain.
González-Ortega A; Virgen del Rocío University Hospital, Research Laboratory on Neuropeptides, Sevilla, Spain.
Salinas-Martín MV; Deparment of Pathology, Juan Ramón Jiménez Hospital, Huelva, Spain.
Carranza A; Virgen del Rocío University Hospital, Research Laboratory on Neuropeptides, Sevilla, Spain.
Garcia-Recio S; Department of Medical Oncology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Almendro V; Department of Medical Oncology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Coveñas R; Institute of Neurosciences of Castilla y León (INCYL), Laboratory of Neuroanatomy of the Peptidergic Systems (Lab. 14), Salamanca, Spain.

Int J Oncol ; 45(4): 1658-72, 2014 Oct.

Article de En | MEDLINE | ID: mdl-25175857

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Substance P / Morpholines / Récepteur de la neurokinine 1 / Antinéoplasiques Limites: Female / Humans Langue: En Journal: Int J Oncol Sujet du journal: NEOPLASIAS Année: 2014 Type de document: Article Pays d'affiliation: Espagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google